Hospira propofol recall expanded; Portable high-tech unit IDs drug fakes;

> Hospira is expanding a recall that began in March of propofol; some containers may be contaminated with sub-visible inert stainless steel particles. Release

> A portable device from Gilden Photonics uses a light to compare spectral signatures, separating counterfeits from real drugs. Article

> SOHM, in Ahmadabad, India, has added 410 square meters of operations space and is separating drug and nutritional product manufacturing. Article

> The FDA has received reports of floating matter in IV bags manufactured by Claris; potentially affected products carry Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Alert

> Siegfried will supply the majority of sodium oxybate, the active pharmaceutical ingredient in Xyrem, to Jazz Pharmaceutical. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.